MEDICINOVA, INC. Increase (Decrease) in Deferred Revenue
MEDICINOVA, INC. (MNOV) reported Increase (Decrease) in Deferred Revenue of -$370.16 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-13
- MEDICINOVA, INC. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was -$428.28K.
- MEDICINOVA, INC. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $58.12K.
- MEDICINOVA, INC. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$151.74K.
- MEDICINOVA, INC. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $521.90K.
- MEDICINOVA, INC. increase (decrease) in deferred revenue for fiscal 2025 was $370.16K.
- MEDICINOVA, INC. increase (decrease) in deferred revenue for fiscal 2024 was $0.00.
- MEDICINOVA, INC. increase (decrease) in deferred revenue for fiscal 2011 was $2.50M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 135 month | Increase (Decrease) in Deferred Revenue 138 month | Increase (Decrease) in Deferred Revenue 147 month | Increase (Decrease) in Deferred Revenue 150 month | Increase (Decrease) in Deferred Revenue 153 month | Increase (Decrease) in Deferred Revenue 156 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$428.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$370.16K 10-Q · filed 2026-08-13 | -$521.90K derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2026-03-31 | $58.12K 10-Q · filed 2026-05-14 | -$93.62K derived: sum of 2 quarters · filed 2026-05-14 | $428.28K derived: sum of 3 quarters · filed 2026-05-14 | $428.28K derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-12-31 | -$151.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $370.16K derived: sum of 2 quarters · filed 2026-03-10 | $370.16K derived: sum of 3 quarters · filed 2026-08-13 | $370.16K 10-K · filed 2026-03-10 | ||||||
| 2025-09-30 | $521.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $521.90K derived: sum of 2 quarters · filed 2026-08-13 | $521.90K 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | ||||||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | |||||||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-10 | |||||||||
| 2013-09-30 | $0.00 derived: 10-Q 156 month − 10-Q 153 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 derived: sum of 3 quarters · filed 2013-11-07 | $2.50M 10-Q · filed 2013-11-07 | ||||||
| 2013-06-30 | $0.00 derived: 10-Q 153 month − 10-Q 150 month · filed 2013-08-08 | $0.00 derived: sum of 2 quarters · filed 2013-08-08 | $2.50M 10-Q · filed 2013-08-08 | |||||||
| 2013-03-31 | $0.00 derived: 10-Q 150 month − 10-K 147 month · filed 2013-05-08 | $2.50M 10-Q · filed 2013-05-08 | ||||||||
| 2012-12-31 | $2.50M 10-K · filed 2013-03-28 | |||||||||
| 2012-03-31 | -$191.17K 10-Q · filed 2012-05-10 | $2.31M 10-Q · filed 2012-05-10 | ||||||||
| 2011-12-31 | $2.50M 10-K · filed 2013-03-28 | $2.50M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |